At this year's European Society of Cardiology (ESC) Congress, the headlines focused on innovation. From AI-enhanced diagnostics and digital health integration to advances in treatment, technology was front and centre.

But beyond the innovation narrative, a more profound shift is taking place.

Cardiovascular disease (CVD) is undergoing a fundamental category transformation. Historically defined through a predominantly cardiac lens, the latest ESC guidelines signal a broader evolution towards whole-person care. The inclusion of dedicated guidance on the management of cardiovascular disease alongside chronic kidney disease (CKD) reflects a growing recognition that patients cannot be treated through a single-disease framework. Instead, prevention, diagnosis and treatment must consider the interconnected nature of health, comorbidities and lived experience.

This is more than a clinical update. It represents a reset of how the category understands disease, delivers care and defines success.

For healthcare brands, and particularly those operating in rare disease, there is an important lesson here. The challenge is no longer simply communicating treatment benefits. It is about evolving alongside a healthcare system that is becoming increasingly personalised, preventative and patient-centred.

 

What Can We Learn From a Category in Transformation?

At Havas Life London, we often ask: how do you change the conversation when the status quo is deeply entrenched?

What we're witnessing in cardiology provides a blueprint for how categories evolve. When a category expands its boundaries, the organisations that lead are those that move beyond promoting products and begin shaping how disease is understood, how patients are engaged and how healthcare professionals make decisions.

 

Three key lessons stood out from ESC:

1. Start with the Patient's Language, Not the Disease Language

Patient centricity has become an industry expectation, but true patient understanding goes beyond research metrics and journey maps.

Patients do not experience disease through the lens of clinical terminology. They describe symptoms, fears, frustrations and aspirations in their own words. When healthcare systems, brands or clinicians fail to understand that language, patients can struggle to be heard and opportunities for earlier recognition and intervention may be missed.

For categories seeking transformation, patient linguistics become a strategic asset. Understanding how patients describe their condition can unlock better engagement, stronger patient-HCP conversations and more meaningful care experiences.

If you aren't capturing the language of the patient, you aren't capturing the truth of the patient.

2. Move Beyond Diagnosis to Context

Technology is transforming diagnosis, but diagnosis alone is no longer enough.

AI is revolutionising the speed and accuracy of disease detection, yet data in isolation lacks human context. The shift we are seeing in cardiovascular disease acknowledges that understanding a patient requires more than identifying a condition. It requires understanding the broader factors that influence outcomes, from comorbidities and lifestyle to emotional and behavioural drivers.

This presents an important challenge for brands. Engagement strategies must evolve beyond awareness programmes focused solely on disease education. They should help stakeholders understand the person behind the condition.

The future belongs to organisations that can connect clinical science with human context, moving beyond diagnosing the patient to understanding the person.

3. Align Expectations Across the Care Journey

One of the clearest lessons from ESC is that better outcomes depend on stronger alignment between patients and healthcare professionals.

When treatment goals differ, engagement suffers and outcomes can stall. Successful treatment increasingly relies on creating a shared understanding of what success looks like and how it can be achieved.

For brands, this means moving beyond transactional messaging. Communication strategies should bridge the gap between patient priorities and clinical objectives, ensuring every stakeholder is working towards the same outcome.

The strongest brands will be those that create shared narratives, not just share information.

From Observation to Influence

Working in the rare disease space continually reinforces the importance of understanding the patient mindset. The transformation taking place in cardiovascular disease demonstrates that meaningful progress happens when patients and healthcare professionals are brought closer together through a shared understanding of disease and treatment goals.

At Havas Life London, we help clients navigate this shift by:

• • Asking “What are the biggest challenges that patients and clinicians are facing?”
  • Uncovering patient insights through advanced linguistic and behavioural research

• Building engagement strategies that connect scientific evidence with lived experience
• Developing brand platforms that align patient, caregiver and HCP needs
• Creating communications that support holistic and personalised care pathways
• Identifying opportunities to redefine category conversations rather than simply participate in them

Working alongside our colleagues at Havas SO and across the wider Havas Health Network, we combine strategic, medical and patient expertise to help shape how diseases are understood, diagnosed and managed.

Because in a transforming category, relevance comes from helping shape the future, not reacting to it.

 

The Opportunity Ahead

The story emerging from ESC is not simply about innovation. It is about reimagining the category itself.

The shift towards integrated, patient-centred care in cardiovascular disease demonstrates that meaningful transformation happens when we change the way people think about disease, not just the way we treat it.

For healthcare brands, the opportunity is clear: evolve engagement strategies to reflect the realities of whole-person care, build stronger connections between patients and healthcare professionals, and help shape the future of the category.

If you're interested in transformation, innovation and redefining how healthcare conversations happen, we'd love to start a conversation.

Contact Natalie Hoegen, Client Partner: [email protected]